The UK Biobank team can be contacted via: 0800 0 276 276; or the UK Biobank website feedback form.
UK Biobank Participant Resource Centre
Based at the University of Cardiff, the UK Biobank Participant Resource Centre (PRC) is the first port of call for participants, scientists and members of the public wishing to find out more about the project. Staff are able to update participants’ contact details, provide information about developments regarding the project and put scientists in touch with the right person. The PRC is open 8am-7pm Monday- Saturday UK time on 0800 0 276 276 (free from landlines, though calls from mobile phones and overseas may be charged).
Access Management Team
The Access team is based at the UK Biobank Coordinating Centre, near Stockport and its role is to help scientists use the UK Biobank resource. The team verifies the identities of individuals requesting access, and will escalate within UK Biobank those applications that warrant closer examination. The Access team works with researchers throughout the time they are using data and/ or samples from UK Biobank. It is led by Mrs Lorraine Gillions, Research Access Administration Manager.
Dr Naomi Allen is a Senior Epidemiologist at Oxford University. She will use her previous experience at the Million Women Study to help develop additional measures of exposure for UK Biobank, thereby expanding the types of research using the resource. One of the planned enhancements that Naomi is working on is the analysis of data from the diet web questionnaire, and other enhancements such as our activity monitor devices to measure physical activity. The Million Women Study is itself a landmark health project. It is investigating the factors that affect health in women aged 50 and over, including use of HRT, diet, childbirth and family history of disease. Scientists are using the resource to investigate the causes of a wide range of cancers, heart disease, fractures and other conditions.
Professor Cathie Sudlow, a clinician and scientist with a particular interest in understanding the causes and prevention of strokes, is UK Biobank’s Chief Scientist and Senior Epidemiologist. Dr Sudlow is Clinical Reader and Honorary Consultant Neurologist at the University of Edinburgh, and continues to look after patients with strokes and other neurological disorders. She holds a number of key positions within stroke research, including chair of the British Association of Stroke Physicians scientific committee, and membership of the International Stroke Genetics Consortium. Cathie’s role will include overseeing UK Biobank’s linkages to health records and working with expert groups to ensure that these records are combined in the best way for health-related research on a range of different conditions. She also looks forward to developing new ideas for improving the resource to make it more useful to the health researchers.
Andrew Trehearne joined UK Biobank shortly before recruitment began in 2007. He has worked extensively within the health communications sector, most notably at the Leukaemia Research Fund (LRF), Imperial Cancer Research Fund and World Cancer Research Fund. AT LRF he was involved in a number of high-profile events, including the Ian Botham Walks, and the launch of the enormously successful Alternative WI Calendar. He also spent much of his time bringing pioneering science to the public’s attention.
Rory Collins was appointed Principal Investigator and Chief Executive of UK Biobank in September 2005. He is co-director of Oxford University’s Clinical Trial Service Unit & Epidemiological Studies Unit (CTSU) and an expert in large scale studies to investigate the causes, prevention and treatment of common disease. He encourages wide use of the UK Biobank resource across the global research community. More information and key publications.
Tim Peakman is Deputy Chief Executive Officer for UK Biobank and has overall responsibility for the day-to-day running of the organisation. Tim started work at UK Biobank in April 2004 as the Director of Operations. With ten years experience as a research scientist in the pharmaceutical industry and four as a management consultant in drug discovery, Tim brings a wide knowledge and experience to UK Biobank. In 2011, Tim was awarded the inaugural Dame Elisabeth Murdoch Visiting Fellowship at the Murdoch Childrens Research Institute in Melbourne. More information.
Simon joined UK Biobank in June 2013 as Director of Operations. With over 12 years’ experience in the life sciences sector plus experience of working within both public funded business support environments and “high-tech” university & corporate “starburst” companies , Simon brings a broad range of expertise and knowledge to UK Biobank. Prior to joining UKB, Simon was involved with various academic steering groups, was a member of (and chaired) the audit committee of the Association for Laboratory Automation and was closely involved with SiLA (a consortium working towards Standardisation in Laboratory Automation). Simon has published a number of papers in peer reviewed scientific journals, presented papers and posters at numerous international conferences and exhibitions, provided copy and content to the scientific press and is a named inventor on the patent for the automated blood fractionation technologies employed at UK Biobank. More information.
Pamela Moore joined UK Biobank in April 2011 as Finance Consultant. She is a Chartered Accountant, who prior to joining UK Biobank was the Finance Director of an international manufacturing company. Before moving into industry, Pamela was a Senior Manager at KPMG where her portfolio included clients from the not-for-profit sector and owner-managed businesses, for whom she provided audit, accounting and taxation services.
Jonathan is the legal counsel and company secretary of UK Biobank. He is an expert in intellectual property, life sciences and data protection law.
Grant Nash, Finance Director
Grant Nash joined UK Biobank in February 2014 as Finance Director. Previous to UK Biobank, Grant was Senior Vice President Finance at Evotec AG which is a provider of early stage drug discover services to pharmaceutical, biotech and charitable organisations. Grant has a strong financial management back-ground and has held responsibility for finance, IT, purchasing and facility teams across a range of global locations. Previous to Evotec, Grant worked at PwC LLP where he qualified as a Chartered Account.